Lung Cancer growth in the youngster is an alarming signal to governing bodies to re-plan their anti-tobacco policies. 80% of Lung cancer is present in stage 3 or stage 4 with no symptoms.
Governing bodies need to follow suggested guidelines by WHO which are based on the strong and well-funded enforcement structures.
Awareness about the negative effects of tobacco consumption is weak in the country. People who are using tobacco in the form of smoke are at higher risk of stroke, heart attack due to damage to the inner lining of arteries. People who are addicted to chewing tobacco are at higher risk of mouth cancer. Carcinogen, a harmful chemical is deposited in the oral cavity lining, according to head and neck oncologists.
According to experts, warning on pack would not work. Ban on sale of tobacco products to children is not implemented properly when most of the sellers are kids who are earning their livelihood. Increasing Tax policy has resulted in cigarette smokers to shift to the cheaper cigarette.
Public awareness that smoking is harmful is lower in India than 12 other countries surveyed in 2017. Only 70% of smokers believe that smoking habit is harmful. Only 57% believe that smoking e-cigarette is as harmful as a normal cigarette. It’s important to address misperception that smoking relaxes the mind. Health professionals have the responsibility of communicating real risks to smokers and their families.
India is the second largest in the number of smokers just below china which accounts for 1 million deaths each year.
According to Dr. Villoo Morawala Patell, Founder & CMD, Avethagen Limited. No organ of the human body is immune to tobacco, so its effect on the lungs can be understood easily. It can further lead to TB, asthma, pneumonia and lung cancer. The government needs to tighten its policies against the ill-effects of tobacco.
First Cardiac Registry under process
Abbott and Apollo Hospital have joined hands for building India’s first cardiac registry to assess the risk of heart disorder and improve preventive care. Both would collect heart health data of patients visiting Apollo Hospitals across the country which would include troponin levels measured Abbott’s High Sensitive Troponin-I blood test.
Cardiovascular diseases are the biggest cause of mortality in India accounting for 25 % mortalities among the age group of 25 to 69 years. Compared to Europeans, the condition affects Indians at least a decade earlier.
The data from the cardiac registry will help researchers to better understand how heart disease affects Indians, as well as patterns in cardiac risk, can help prevent CVD and enable physicians and patients to manage their condition much more efficiently. This would help to save countless lives in the future.
Dr. Sangita Reddy, joint managing director, Apollo Hospital, said, “Data has been central to improving the standard of care across the world. By setting up a national cardiac registry in India, we aim to collect invaluable data that would enable us to improve cardiac care and save a number of lives.”
A pilot test has been conducted last year in different cities for Apollo hospital for its employees to understand their risk of developing heart disease. More than 16,000 Apollo employees have been screened and data has been added in the registry.
“Being a leader in heart health, Apollo is pioneered the use of Abbott’s blood test in India. Our employee has been the first to benefit from this initiative. Making this blood test part of routine checkup would enable us to capture more data” added Dr. Sangita Reddy.
Preliminary finding from the pilot indicates that the test is able to identify a younger and wider set of patients developing heart diseases ranging from low to medium to high. 80% of people participating in the pilot tests were under the age group 45 and enabled researchers to find high-risk patients in the same age group.
Agim Beshiri, Senior Medical Director, Global Medical and Scientific Affairs at Abbott’s diagnostics business said, “This technology has the potential for doctors to identify those at risk of developing heart disease. We have a simple and accessible blood test that is specific to heart, sensitive to women and works for all age groups to address the onset of heart disease in India.”
Narendra Varde, general manager and country head at Abbott’s diagnostic business said, “This is a unique partnership that will transform India’s approach to cardiac care. Armed with ahead of time understanding cardiac profiles, doctors and surgeons will be better prepared to manage health outputs.”